Arbutus Biopharma Corp. (ABUS)
4.09
+0.06
(+1.49%)
USD |
NASDAQ |
Nov 13, 16:00
4.095
0.00 (0.00%)
After-Hours: 19:59
Arbutus Biopharma Gross Profit Margin (Quarterly) : 96.66% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.66% |
| June 30, 2026 | 98.92% |
| March 31, 2026 | 99.99% |
| December 31, 2025 | 98.95% |
| September 30, 2025 | 97.92% |
| June 30, 2025 | 99.90% |
| March 31, 2025 | 81.29% |
| December 31, 2024 | 78.84% |
| September 30, 2024 | 74.91% |
| June 30, 2024 | 79.37% |
| March 31, 2024 | 76.83% |
| December 31, 2023 | 83.26% |
| September 30, 2023 | 92.08% |
| June 30, 2023 | 92.65% |
| March 31, 2023 | 95.01% |
| December 31, 2022 | 95.08% |
| September 30, 2022 | 94.24% |
| June 30, 2022 | 97.31% |
| March 31, 2022 | 96.87% |
| December 31, 2021 | 86.68% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 91.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Gossamer Bio, Inc. | 99.41% |
| ACADIA Pharmaceuticals, Inc. | 89.75% |
| Alnylam Pharmaceuticals, Inc. | 75.19% |
| Anika Therapeutics, Inc. | 61.57% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 144.9% |
| Return on Assets | 101.5% |
| Return on Invested Capital | 141.3% |
| Operating Margin (Quarterly) | -3.44K% |
| Return on Net Operating Assets | 21.88K% |